Zhongchao Inc. (ZCMD): Price and Financial Metrics
GET POWR RATINGS... FREE!
ZCMD Stock Summary
- With a market capitalization of $34,158,399, Zhongchao Inc has a greater market value than only 6.35% of US stocks.
- Zhongchao Inc's stock had its IPO on February 24, 2020, making it an older stock than merely 5.41% of US equities in our set.
- The ratio of debt to operating expenses for Zhongchao Inc is higher than it is for about merely 6.57% of US stocks.
- If you're looking for stocks that are quantitatively similar to Zhongchao Inc, a group of peers worth examining would be ISDR, NLS, ASTE, TNC, and ANY.
- Visit ZCMD's SEC page to see the company's official filings. To visit the company's web site, go to www.izcmd.com.
ZCMD Valuation Summary
- ZCMD's price/sales ratio is 2.5; this is 52.83% lower than that of the median Technology stock.
- ZCMD's EV/EBIT ratio has moved down 20.6 over the prior 18 months.
- ZCMD's price/sales ratio has moved down 5.3 over the prior 18 months.
Below are key valuation metrics over time for ZCMD.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| ZCMD | 2021-09-01 | 2.5 | 1.4 | 10.0 | 5.9 |
| ZCMD | 2021-08-31 | 2.5 | 1.4 | 10.1 | 6.0 |
| ZCMD | 2021-08-30 | 2.5 | 1.4 | 10.0 | 5.9 |
| ZCMD | 2021-08-27 | 2.5 | 1.4 | 10.0 | 5.9 |
| ZCMD | 2021-08-26 | 2.5 | 1.4 | 9.9 | 5.9 |
| ZCMD | 2021-08-25 | 2.5 | 1.4 | 10.0 | 5.9 |
ZCMD's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- ZCMD has a Quality Grade of C, ranking ahead of 45.59% of graded US stocks.
- ZCMD's asset turnover comes in at 0.685 -- ranking 24th of 51 Personal Services stocks.
- 500 - Internal server error
The table below shows ZCMD's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2020-12-31 | 0.685 | 0.660 | 0.409 |
| 2020-12-31 | 0.685 | 0.660 | 0.409 |
| 2019-12-31 | 0.937 | 0.687 | 0.772 |
ZCMD Stock Price Chart Interactive Chart >
ZCMD Price/Volume Stats
| Current price | $1.23 | 52-week high | $2.12 |
| Prev. close | $1.19 | 52-week low | $1.05 |
| Day low | $1.19 | Volume | 6,400 |
| Day high | $1.26 | Avg. volume | 66,356 |
| 50-day MA | $1.30 | Dividend yield | N/A |
| 200-day MA | $1.62 | Market Cap | 22.24M |
Zhongchao Inc. (ZCMD) Company Bio
Zhongchao, Inc. is a holding company that engages in the provision of healthcare information, education, and training services. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference & workshops, continuing education courses, articles & short videos with educational healthcare content to healthcare professionals as well as the public. The company was founded by Wei Guang Yang on April 16, 2019 and is headquartered in Shanghai, China.
Latest ZCMD News From Around the Web
Below are the latest news stories about Zhongchao Inc that investors may wish to consider to help them evaluate ZCMD as an investment opportunity.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayGood morning! |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayWelcome back! |
Capital Allocation Trends At Zhongchao (NASDAQ:ZCMD) Aren't IdealIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll... |
Zhongchao Inc. Announces Its Patient Management System Improves Its Liver Cancer Patients' Duration of Therapy by 40%, Promoting Successful TreatmentZhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patients the patient management platform, today announced its self-developed patient management system improves Duration of Therapy ("DOT") by 40.4% for liver cancer patients, which contributes to the maximum efficiency of drugs, successful treatment and longer patient survival |
Zhongchao Inc. Launches Hematology MDT Training Platform to Improve Diagnosis and TreatmentZhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patients the patient management platform, today announced the launch of its multidisciplinary treatment ("MDT") clinical thinking training platform for hematology ("Hematology MDT Platform"). The Hematology MDT Platform provides clinicians with a channel to learn multidisciplin |
ZCMD Price Returns
| 1-mo | -5.38% |
| 3-mo | N/A |
| 6-mo | -34.22% |
| 1-year | -32.79% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -30.90% |
| 2021 | 4.71% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...